Pharmaceutical companies are in a fierce competition to match the success of industry leaders Eli Lilly and Novo Nordisk in the weight-loss drug sector. The current focus is on enhancing the patient experience.
While the demand for these new weight-loss medications is high, there are notable challenges. Patients often face the inconvenience of weekly injections. Additionally, there are undesirable side effects such as gastrointestinal discomfort and the potential for muscle and bone loss.
This competitive environment drives drugmakers to develop improved alternatives that address these issues, aiming to offer more effective and patient-friendly solutions.
Early Detection of Atherosclerosis and Heart Disease Prevention 
Church Attendance Linked to Increased Sexual Satisfaction for Married Couples 
Dining with Loved Ones May Benefit Blood Sugar Levels 
Urgent Need for Action in East Africa’s Food Crisis 
Facing Terminal Illness: Embracing Life’s Moments 
Eating with Partners May Impact Blood Sugar Regulation